Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Acceleron
Company Monitoring Page for Acceleron
latest headlines for company on cafepharma
Acceleron's PAH drug gets the FDA's red carpet treatment with breakthrough status
Endpoints
Wed, 04/8/20 - 10:37 am
Tags:
Acceleron
,
PAH
,
FDA
,
breakthrough therapy
,
sotatercept
Bristol Myers Squibb, Acceleron get FDA nod for Reblozyl to treat anaemia with lower-risk MDS
Pharmaceutical Business Review
Mon, 04/6/20 - 10:30 am
Tags:
Bristol-Myers Squibb
,
Acceleron
,
FDA
,
Reblozyl
,
MDS
Go or no go? Covid-19 upstages US regulatory decisions
EP Vantage
Tue, 03/24/20 - 10:30 am
Tags:
FDA
,
regulatory
,
Bristol-Myers Squibb
,
ozanimod
,
Esteve
,
E-58425
,
Fabre-Kramer
,
AstraZeneca
,
Imfinzi
,
Astellas
,
Vesicare
,
AbbVie
,
Neurocrine
,
Orlissa
,
Sanofi
,
MenQuadfi
,
opicapone
,
Acceleron
,
Reblozyl
Acceleron ditches midstage drug after flop
Fierce Biotech
Tue, 03/10/20 - 10:38 am
Tags:
Acceleron
,
Charcot-Marie-Tooth
,
clinical trials
,
ACE-083
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
Sun, 02/23/20 - 06:17 pm
Tags:
beta thalassemia
,
rare disease
,
drug development
,
Acceleron
,
Bristol-Myers Squibb
,
Bluebird Bio
,
Sangamo Therapeutics
,
Vertex Pharmaceuticals
,
Editas Medicine
,
Syros Pharmaceuticals
Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Tags:
Acceleron
,
sotatercept
,
PAH
,
JNJ
,
Bellerophon Therapeutics
,
United Therapeutics
,
Vivus
,
Arena
,
Novartis
Acceleron Shares Surge as Its Hypertension Drug Meets Trial Endpoints
Motley Fool
Mon, 01/27/20 - 10:47 pm
Tags:
Acceleron
,
PAH
,
clinical trials
,
sotatercept
Acceleron signs pulmonary research and discovery deal with Fulcrum Therapeutics
Pharmaceutical Business Review
Wed, 01/1/20 - 06:51 pm
Tags:
Acceleron
,
Fulcrum Therapeutics
,
R&D
,
small molecule drugs
,
pulmonary
Bristol-Myers Squibb, Acceleron announce FDA advisory committee will review Reblozyl for use in patients with MDS
Pharmaceutical Business Review
Wed, 12/4/19 - 10:34 am
Tags:
Bristol-Myers Squibb
,
Acceleron
,
FDA
,
Reblozyl
,
myelodysplastic syndromes
FDA Approves Celgene and Acceleron's Treatment for Rare Blood Disease
BioSpace
Sat, 11/9/19 - 12:13 pm
Tags:
Celgene
,
Acceleron
,
Reblozyl
,
anemia
,
beta thalassemia
Another failed midstage asset for Acceleron, another pipeline test dumped
Fierce Biotech
Tue, 09/17/19 - 10:19 am
Tags:
Acceleron
,
clinical trials
,
ACE-083
Acceleron gets FDA orphan drug designation for sotatercept in pulmonary arterial hypertension
Pharmaceutical Business Review
Tue, 09/10/19 - 11:06 am
Tags:
Acceleron
,
orphan drugs
,
sotatercept
,
PAH
In a much-needed positive for BMS, Celgene gains FDA review for blockbuster hopeful
Fierce Biotech
Tue, 06/4/19 - 11:02 am
Tags:
Celgene
,
Bristol-Myers Squibb
,
Acceleron
,
luspatercept
,
MDS
,
beta thalassemia
Celgene and Acceleron Submit BLA for Luspatercept
CP Wire
Fri, 04/5/19 - 11:42 am
Tags:
Celgene
,
Acceleron
,
luspatercept
,
myelodysplastic syndrome
,
beta thalassemia
Fri, 04/5/19 - 10:44 am
Tags:
Celgene
,
Acceleron
,
luspatercept
Acceleron, Stemline price upsized follow-ons
BioCentury
Wed, 01/16/19 - 11:57 am
Tags:
Acceleron
,
Stemline Therapeutics
,
Celgene
,
Elzonris tagraxofusp-erzs
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Tags:
Celgene
,
M&A
,
Juno Therapeutics
,
Kite Therapeutics
,
Bluebird Bio
,
Agios Pharmaceuticals
,
Jounce Therapeutics
,
BieGene
,
Acceleron
BMS deal weighs on Celgene partners
BioCentury
Thu, 01/3/19 - 11:45 pm
Tags:
M&A
,
Celgene
,
Bristol-Myers Squibb
,
Acceleron
,
BeiGene
Top Biotech Stocks to Watch at ASH 2018
Yahoo/Motley Fool
Sun, 12/2/18 - 12:37 pm
Tags:
ASH2018
,
Celgene
,
Bluebird Bio
,
Acceleron
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Tags:
Acceleron
,
luspatercept
,
Bluebird Bio
,
bb21217
,
Amgen
,
AMG 420
Pages
« first
‹ previous
1
2
3
4
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.